Plus Therapeutics Inc (PSTV)
1.1700 +0.0300 (+2.63%) 01/14/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Tue, Jan 14th, 2025
Results
download Want to compare other data? Select FieldsSymbol | PSTV | ZTS | TAK | UTHR | NBIX |
Company | Plus Therapeutics Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Neurocrine Bioscienc |
Price Information | |||||
Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
Open | 1.1500 | 166.42 | 13.03 | 361.97 | 142.46 |
High | 1.2000 | 167.14 | 13.10 | 366.48 | 144.24 |
Low | 1.1500 | 161.58 | 13.00 | 357.55 | 139.39 |
Last | 1.1700 | 164.41 | 13.04 | 364.70 | 139.51 |
Change | +0.0300 | -1.91 | +0.05 | +1.82 | -3.52 |
% Change | +2.63% | -1.15% | +0.38% | +0.50% | -2.46% |
Volume | 16,100 | 3,608,200 | 1,694,200 | 294,900 | 985,200 |
20-Day Average Volume | 55,440 | 2,533,285 | 1,790,850 | 309,780 | 1,094,900 |
Previous Close | 1.1400 | 166.32 | 12.99 | 362.88 | 143.03 |
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
Has Options | No | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 1.1430 | 165.94 | 13.19 | 362.21 | 137.02 |
20-Day Raw Stochastic | 57.65% | 17.97% | 28.57% | 43.52% | 74.61% |
20-Day Relative Strength | 46.97% | 41.22% | 40.42% | 50.16% | 61.04% |
Weighted Alpha | -38.20 | -13.49 | -11.61 | +58.82 | +4.43 |
Today's Opinion | 88% Sell | 88% Sell | 88% Sell | 40% Buy | 56% Buy |
Previous Opinion | 100% Sell | 88% Sell | 88% Sell | 40% Buy | 56% Buy |
Last Month's Opinion | 64% Sell | 40% Sell | 56% Sell | 64% Buy | 24% Sell |
Performance | |||||
5-Days | |||||
%Chg | -7.14% since 01/06/25 | -0.90% since 01/06/25 | -1.95% since 01/06/25 | +2.62% since 01/06/25 | +1.94% since 01/06/25 |
Low | 1.1150 on 01/13/25 | 161.36 on 01/07/25 | 12.86 on 01/13/25 | 355.80 on 01/07/25 | 136.84 on 01/07/25 |
High | 1.3500 on 01/08/25 | 167.14 on 01/14/25 | 13.45 on 01/07/25 | 368.36 on 01/13/25 | 144.24 on 01/14/25 |
1-Month | |||||
%Chg | -7.87% since 12/13/24 | -7.73% since 12/13/24 | -2.83% since 12/13/24 | +0.80% since 12/13/24 | +10.11% since 12/13/24 |
Low | 0.9250 on 12/19/24 | 160.59 on 01/03/25 | 12.86 on 01/13/25 | 350.60 on 12/19/24 | 127.35 on 12/16/24 |
High | 1.3500 on 01/08/25 | 179.29 on 12/16/24 | 13.45 on 01/07/25 | 383.00 on 12/18/24 | 144.24 on 01/14/25 |
3-Month | |||||
%Chg | -11.36% since 10/14/24 | -14.66% since 10/14/24 | -9.07% since 10/14/24 | +2.13% since 10/14/24 | +19.81% since 10/14/24 |
Low | 0.9250 on 12/19/24 | 160.59 on 01/03/25 | 12.86 on 01/13/25 | 342.02 on 10/23/24 | 113.88 on 10/25/24 |
High | 1.4900 on 11/06/24 | 196.55 on 10/17/24 | 14.36 on 10/18/24 | 417.82 on 11/08/24 | 144.24 on 01/14/25 |
6-Month | |||||
%Chg | -35.71% since 07/12/24 | -8.17% since 07/12/24 | -2.98% since 07/12/24 | +13.48% since 07/12/24 | -5.37% since 07/12/24 |
Low | 0.9250 on 12/19/24 | 160.59 on 01/03/25 | 12.86 on 01/13/25 | 310.00 on 07/31/24 | 110.95 on 10/03/24 |
High | 2.0700 on 07/17/24 | 200.33 on 09/19/24 | 15.08 on 08/23/24 | 417.82 on 11/08/24 | 157.98 on 08/01/24 |
Key Statistics | |||||
Market Capitalization, $K | 6,722 | 75,037,768 | 41,332,556 | 16,200,778 | 14,481,359 |
Shares Outstanding, K | 5,896 | 451,165 | 3,181,875 | 44,645 | 101,247 |
Annual Sales | 4,910,000 | 8,544,000,000 | 29,419,960,000 | 2,327,500,000 | 1,887,100,000 |
Annual Net Income | -13,320,000 | 2,344,000,000 | 994,060,000 | 984,800,000 | 249,700,000 |
Last Quarter Sales | 1,460,000 | 2,388,000,000 | 7,903,930,000 | 748,900,000 | 622,100,000 |
Last Quarter Net Income | -2,870,000 | 682,000,000 | 618,620,000 | 309,100,000 | 129,800,000 |
60-Month Beta | 0.70 | 0.89 | 0.51 | 0.57 | 0.33 |
Per-Share Information | |||||
Most Recent Earnings | -0.46 on 11/14/24 | 1.58 on 11/04/24 | 0.44 on 10/31/24 | 6.39 on 10/30/24 | 1.24 on 10/30/24 |
Latest Earnings Date | 03/04/25 | 02/13/25 | 02/06/25 | 02/19/25 | 02/05/25 |
Most Recent Dividend | N/A | 0.432 on 10/31/24 | 0.267 on 09/30/24 | N/A | N/A |
Next Ex-Dividends Date | N/A | 01/21/25 | 09/30/24 | N/A | N/A |
Ratios | |||||
Price/Earnings ttm | 0.00 | 28.35 | 8.58 | 16.03 | 37.77 |